Article
A novel monoclonal antibody reveals a conformational alteration shared by amyotrophic lateral sclerosis-linked SOD1 mutants.
Annals of neurology - 1 Nov 2012
Fujisawa Takao, Homma Kengo, Yamaguchi Namiko, Kadowaki Hisae, Tsuburaya Naomi, Naguro Isao, Matsuzawa Atsushi, Takeda Kohsuke, Takahashi Yuji, Goto Jun, Tsuji Shoji, Nishitoh Hideki, Ichijo Hidenori
Abstract excerpt
OBJECTIVE: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that is characterized by the selective loss of upper and lower motoneurons. Although >100 different Cu, Zn superoxide dismutase (SOD1) mutations have been identified in ALS patients, it remains controversial whether all of them are disease-causative mutations. Therefore, it is necessary to develop molecular mechanism-based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
